69 related articles for article (PubMed ID: 18618574)
1. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
Han JY; Lee GK; Jang DH; Lee SY; Lee JS
Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population.
Ørsted DD; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
J Exp Med; 2007 Jun; 204(6):1295-301. PubMed ID: 17535973
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphisms in the p53 signaling pathway.
Grochola LF; Zeron-Medina J; Mériaux S; Bond GL
Cold Spring Harb Perspect Biol; 2010 May; 2(5):a001032. PubMed ID: 20452958
[TBL] [Abstract][Full Text] [Related]
4. Sex-Specific Associations of
Ward SV; Autuori I; Luo L; LaPilla E; Yoo S; Sharma A; Busam KJ; Olilla DW; Dwyer T; Anton-Culver H; Zanetti R; Sacchetto L; Cust AE; Gallagher RP; Kanetsky PA; Rosso S; Begg CB; Berwick M; Thomas NE; Orlow I;
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345045
[No Abstract] [Full Text] [Related]
5. MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN.
He W; Long J; Xian L; Pang F; Su L; Wei S; Wei B; Hu Y
Exp Ther Med; 2012 Oct; 4(4):569-576. PubMed ID: 23170107
[TBL] [Abstract][Full Text] [Related]
6. Detection of functional single-nucleotide polymorphisms that affect apoptosis.
Harris SL; Gil G; Robins H; Hu W; Hirshfield K; Bond E; Bond G; Levine AJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16297-302. PubMed ID: 16260726
[TBL] [Abstract][Full Text] [Related]
7. Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.
Zienolddiny S; Skaug V
Lung Cancer (Auckl); 2012; 3():1-14. PubMed ID: 28210120
[TBL] [Abstract][Full Text] [Related]
8. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
[TBL] [Abstract][Full Text] [Related]
9. Association of
Duncan A; Nousome D; Ricks R; Kuo HC; Ravindranath L; Dobi A; Cullen J; Srivastava S; Chesnut GT; Petrovics G; Kohaar I
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239075
[TBL] [Abstract][Full Text] [Related]
10. Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.
Jiang J; Chen HN; Jin P; Zhou L; Peng L; Huang Z; Qin S; Li B; Ming H; Luo M; Xie N; Gao W; Nice EC; Yu Q; Huang C
Signal Transduct Target Ther; 2023 Feb; 8(1):65. PubMed ID: 36788227
[TBL] [Abstract][Full Text] [Related]
11. A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.
Babu G; Bin Islam S; Khan MA
Mol Biol Rep; 2022 Jul; 49(7):6725-6739. PubMed ID: 35277785
[TBL] [Abstract][Full Text] [Related]
12. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
13. A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population.
Reza HA; Anamika WJ; Chowdhury MMK; Mostafa MG; Uddin MA
Korean J Intern Med; 2020 May; 35(3):672-681. PubMed ID: 32392664
[TBL] [Abstract][Full Text] [Related]
14. Association of rs1042522 SNP with Clinicopathologic Factors of Breast Cancer Patients in the Markazi Province of Iran.
Anoushirvani AA; Aghabozorgi R; Ahmadi A; Arjomandzadegan M; Sahraei M; Khalili S; Fereydouni T; Khademi Z
Open Access Maced J Med Sci; 2018 Dec; 6(12):2277-2282. PubMed ID: 30607176
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes.
Guacci A; Cordella A; Rocco T; Giurato G; Nassa G; Rizzo F; Carlomagno C; Pepe S; Tarallo R; Weisz A
J Clin Lab Anal; 2018 Jul; 32(6):e22418. PubMed ID: 29484706
[TBL] [Abstract][Full Text] [Related]
16.
Deben C; Op de Beeck K; Van den Bossche J; Jacobs J; Lardon F; Wouters A; Peeters M; Van Camp G; Rolfo C; Deschoolmeester V; Pauwels P
J Cancer; 2017; 8(12):2154-2162. PubMed ID: 28819417
[No Abstract] [Full Text] [Related]
17. Study of polymorphisms in the
Anaya-Pava EJ; Nares-Cisneros J; Cárdenas-Hernández RI; Jaramillo-Rodríguez Y; Zambrano-Galván G
Mol Vis; 2017; 23():20-25. PubMed ID: 28210099
[TBL] [Abstract][Full Text] [Related]
18. MDM2 gene polymorphisms and risk of classic Kaposi's sarcoma among Iranian patients.
Varmazyar S; Marashi SM; Shoja Z; Tornesello ML; Buonaguro FM; Shahmahmoodi S; Safaie-Naraghi Z; Jalilvand S
Med Microbiol Immunol; 2017 Apr; 206(2):157-163. PubMed ID: 28083704
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
Kumari A; Bahl C; Singh N; Behera D; Sharma S
Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
[TBL] [Abstract][Full Text] [Related]
20. Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.
Enokida Y; Shimizu K; Atsumi J; Kakegawa S; Takase Y; Kaira K; Yashima H; Araki T; Nakazawa S; Ohtaki Y; Nagashima T; Alexander L; Usui K; Ishikawa T; Hayashizaki Y; Takeyoshi I
Cancer Med; 2016 Aug; 5(8):1791-801. PubMed ID: 27228500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
